Cargando…

Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War?

Heart failure represents an end-stage phenotype of a number of cardiovascular diseases and is generally associated with a poor prognosis. A number of organized battles fought over the last two to three decades have resulted in considerable advances in treatment including the use of drugs that interf...

Descripción completa

Detalles Bibliográficos
Autor principal: Atherton, John J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820562/
https://www.ncbi.nlm.nih.gov/pubmed/24278681
http://dx.doi.org/10.6064/2012/279731
_version_ 1782290158854340608
author Atherton, John J.
author_facet Atherton, John J.
author_sort Atherton, John J.
collection PubMed
description Heart failure represents an end-stage phenotype of a number of cardiovascular diseases and is generally associated with a poor prognosis. A number of organized battles fought over the last two to three decades have resulted in considerable advances in treatment including the use of drugs that interfere with neurohormonal activation and device-based therapies such as implantable cardioverter defibrillators and cardiac resynchronization therapy. Despite this, the prevalence of heart failure continues to rise related to both the aging population and better survival in patients with cardiovascular disease. Registries have identified treatment gaps and variation in the application of evidenced-based practice, including the use of echocardiography and prescribing of disease-modifying drugs. Quality initiatives often coupled with multidisciplinary, heart failure disease management promote self-care and minimize variation in the application of evidenced-based practice leading to better long-term clinical outcomes. However, to address the rising prevalence of heart failure and win the war, we must also turn our attention to disease prevention. A combined approach is required that includes public health measures applied at a population level and screening strategies to identify individuals at high risk of developing heart failure in the future.
format Online
Article
Text
id pubmed-3820562
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-38205622013-11-25 Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War? Atherton, John J. Scientifica (Cairo) Review Article Heart failure represents an end-stage phenotype of a number of cardiovascular diseases and is generally associated with a poor prognosis. A number of organized battles fought over the last two to three decades have resulted in considerable advances in treatment including the use of drugs that interfere with neurohormonal activation and device-based therapies such as implantable cardioverter defibrillators and cardiac resynchronization therapy. Despite this, the prevalence of heart failure continues to rise related to both the aging population and better survival in patients with cardiovascular disease. Registries have identified treatment gaps and variation in the application of evidenced-based practice, including the use of echocardiography and prescribing of disease-modifying drugs. Quality initiatives often coupled with multidisciplinary, heart failure disease management promote self-care and minimize variation in the application of evidenced-based practice leading to better long-term clinical outcomes. However, to address the rising prevalence of heart failure and win the war, we must also turn our attention to disease prevention. A combined approach is required that includes public health measures applied at a population level and screening strategies to identify individuals at high risk of developing heart failure in the future. Hindawi Publishing Corporation 2012 2012-12-20 /pmc/articles/PMC3820562/ /pubmed/24278681 http://dx.doi.org/10.6064/2012/279731 Text en Copyright © 2012 John J. Atherton. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Atherton, John J.
Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War?
title Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War?
title_full Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War?
title_fullStr Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War?
title_full_unstemmed Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War?
title_short Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War?
title_sort chronic heart failure: we are fighting the battle, but are we winning the war?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820562/
https://www.ncbi.nlm.nih.gov/pubmed/24278681
http://dx.doi.org/10.6064/2012/279731
work_keys_str_mv AT athertonjohnj chronicheartfailurewearefightingthebattlebutarewewinningthewar